Issued Patents All Time
Showing 1–15 of 15 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10307404 | Ocular formulations for drug-delivery to the posterior segment of the eye | Paul G. CHANEY, Martin B. Wax | 2019-06-04 |
| 10183014 | Ocular formulations for drug-delivery and protection of the anterior segment of the eye | Paul G. CHANEY, Martin B. Wax | 2019-01-22 |
| 10092549 | Ocular formulations for drug-delivery to the posterior segment of the eye | Paul G. CHANEY, Martin B. Wax | 2018-10-09 |
| 9814702 | Ocular formulations for drug-delivery and protection of the anterior segment of the eye | Paul G. CHANEY, Martin B. Wax | 2017-11-14 |
| 9623011 | Ocular formulations for drug-delivery and protection of the anterior segment of the eye | Paul G. CHANEY, Martin B. Wax | 2017-04-18 |
| 9446026 | Ocular formulations for drug-delivery to the posterior segment of the eye | Paul G. CHANEY, Martin B. Wax | 2016-09-20 |
| 9422556 | RNAi-related inhibition of TNF-alpha signaling pathway for treatment of ocular angiogenesis | Jon E. Chatterton, Abbot F. Clark, Martin B. Wax, Adrian M. Timmers | 2016-08-23 |
| 9139834 | RNAi-related inhibition of TNF alpha signaling pathway for treatment of ocular angiogenesis | Jon E. Chatterton, Abbot F. Clark, Martin B. Wax, Adrian M. Timmers | 2015-09-22 |
| 8940887 | RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesis | Jon E. Chatterton | 2015-01-27 |
| 8865670 | RNAi-related inhibition of TNFα signaling pathway for treatment of glaucoma | Jon E. Chatterton, Abbot F. Clark, Martin B. Wax, Adrian M. Timmers | 2014-10-21 |
| 8754202 | RNAi-related inhibition of TNFα signaling pathway for treatment of ocular angiogenesis | Jon E. Chatterton, Abbot F. Clark, Martin B. Wax, Adrian M. Timmers | 2014-06-17 |
| 8722015 | Compositions and methods for treatment of angiogenesis-associated ocular disorders | Andrius Kazlauskas, Magdalena Staniszewska, Carmelo Romano, Robert Landers | 2014-05-13 |
| 8471000 | RNAi-mediated inhibition of HIF1A for treatment of ocular angiogenesis | Jon E. Chatterton | 2013-06-25 |
| 7981870 | RNAi-mediated inhibition of H1F1A for treatment of ocular angiogenesis | Jon E. Chatterton | 2011-07-19 |
| 7879905 | 5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses | Peter G. Klimko, Mark R. Hellberg, Daniel A. Gamache | 2011-02-01 |